INTT on NYSE
INTEST CORP
American Instruments For Meas and Testing of Electricity and Elec Signals company2
In its 2026 annual report the company says: “We are a global supplier of innovative test and process technology solutions for use in manufacturing and testing across a wide range of markets including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security and Other. We operate our business worldwide, sell our products both domestically and internationally and manufacture our products in the U.S., Canada, Italy and began limited manufacturing in Malaysia in the fourth quarter of 2025.”5 It is headquartered in Mount Laurel, United States.2 Its shares trade on NYSE under the symbol INTT.2
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with FREQUENCY ELECTRONICS INC, Aehr Test Systems or TRANSCAT INC, or pick any stock.
- TickerINTT on NYSE2
- IndustryInstruments For Meas & Testing of Electricity & Elec Signals2
- HeadquartersMount Laurel, United States2
- Incorporated inDE3
- Business address804 East Gate Dr., Suite 200, Mt. Laurel, Nj 080543
- Filer categoryAccelerated filer, Smaller reporting company3
- Legal formCorporation2
- LEI549300RJJBPHDOAVDU152
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O ATA CORPORATE SERVICES, LLC, 19801 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 27263082
See how the biggest companies compare on our leaderboards
InTest Corporation, headquartered in Mount Laurel, New Jersey, was incorporated in New Jersey in 1981 and reincorporated in Delaware in April 1997. We completed our initial public offering in June 1997 and currently trade on the NYSE American stock exchange under the symbol “ INTT .” The consolidated entity is comprised of InTest Corporation and our wholly owned subsidiaries which comprise our six businesses: Electro Mechanical Semiconductor (“ EMS ”), Acculogic, Alfamation ™ , InTest Thermal Solutions (“ ITS ”), Ambrell ® and Videology ® .5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
43.0%Gross margin6
-3.3%Operating margin6
-2.2%Net margin6
-12.9%Revenue growth, 20256
-2.4%Return on equity6
0.01×Debt to equity6
$5.7MFree cash flow6
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Thermal Process brought in 19% of the revenue INTEST CORP broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Thermal Process | $33.8M | $21.5M |
| Thermal Testing Products | $17.8M | $20.4M |
| Alfamation | $23.4M | $19.9M |
| Semiconductor Production Test Products | $24.1M | $18.8M |
| Service and Other Products | $14.6M | $17.1M |
| Video Imaging | $7.6M | $8.1M |
| Flying Probe and In-circuit Testers | $9.3M | $8.0M |
Business segments
Electronic Test brought in 49% of the revenue INTEST CORP broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Electronic Test | $63.9M | $56.2M |
| Environmental Technologies | $28.9M | $29.3M |
| Process Technologies | $37.9M | $28.3M |
Regions
Outside the United States brought in 57% of the revenue INTEST CORP broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| Outside the United States | $80.9M | $64.7M |
| United States | $49.8M | $49.1M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue57¢$64.9M
- Research and development8¢$9.4M
- Other costs34¢$38.8M
- Income tax1¢$695.0K
Out of $113.8M in revenue.6 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending22¢$1.6M
- Kept or used elsewhere78¢$5.7M
Out of $7.3M of cash from operations.6
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $113.8M | $130.7M |
| Cost of revenue | $64.9M | $75.3M |
| Gross profit | $48.9M | $55.4M |
| Selling expense | $16.8M | $17.4M |
| Engineering and product development expense | $9.4M | $8.5M |
| General and administrative expense | $22.2M | $23.6M |
| Amortization of acquired intangible assets | $3.3M | $2.5M |
| Charges | $850.0K | $0 |
| Total operating expenses | $52.6M | $52.0M |
| Operating (loss) income | -$3.7M | $3.4M |
| Interest expense | -$450.0K | -$846.0K |
| Other income | $953.0K | $906.0K |
| (Loss) earnings before income tax (benefit) expense | -$3.2M | $3.5M |
| Income tax (benefit) expense | -$695.0K | $563.0K |
| Net (loss) earnings | -$2.5M | $2.9M |
| Basic (in USD per share) | -$0.21 | $0.24 |
| Diluted (in USD per share) | -$0.21 | $0.24 |
| Basic (in shares) | 12.2M shares | 12.2M shares |
| Diluted (in shares) | 12.2M shares | 12.2M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $14.2M | $19.8M | |
| Restricted cash | $3.8M | $0 | |
| Trade accounts receivable, net of allowance for credit losses of $375 and $423, respectively | $25.9M | $29.5M | |
| Inventories | $31.6M | $26.8M | |
| Prepaid expenses and other current assets | $3.1M | $2.6M | |
| Total current assets | $78.6M | $78.8M | |
| Property and equipment, net of accumulated depreciation of $10,083 and $8,830, respectively | $4.8M | $4.5M | |
| Right-of-use assets, net | $9.1M | $10.8M | |
| Goodwill | $32.4M | $30.7M | $21.7M |
| Intangible assets, net | $24.9M | $26.4M | |
| Deferred tax assets | $775.0K | $67.0K | |
| Other assets | $789.0K | $1.1M | |
| Total assets | $151.3M | $152.3M | |
| Current portion of long-term debt | $6.1M | $7.5M | |
| Current portion of operating lease liabilities | $2.1M | $2.0M | |
| Accounts payable | $11.2M | $8.0M | |
| Customer deposits and deferred revenue | $6.4M | $5.0M | |
| Accrued expenses and other current liabilities | $10.0M | $9.5M | |
| Total current liabilities | $35.8M | $31.9M | |
| Operating lease liabilities, net of current portion | $7.4M | $9.0M | |
| Long-term debt, net of current portion | $1.4M | $7.5M | |
| Contingent consideration, net of current portion | $356.0K | $825.0K | |
| Deferred revenue, net of current portion | $1.1M | $1.4M | |
| Other liabilities | $1.7M | $1.7M | |
| Total liabilities | $47.7M | $52.5M | |
| Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding | $0 | $0 | |
| Common stock, $0.01 par value; 20,000,000 shares authorized; 12,570,865 and 12,457,658 shares issued, respectively; 12,488,788 and 12,378,276 shares outstanding, respectively | $125.0K | $124.0K | |
| Additional paid-in capital | $59.4M | $57.7M | |
| Retained earnings | $42.6M | $45.1M | |
| Accumulated other comprehensive earnings (loss) | $2.5M | -$2.1M | |
| Treasury stock, at cost; 82,077 and 79,382 shares, respectively | -$959.0K | -$942.0K | |
| Total stockholders equity | $103.6M | $99.8M | $96.3M |
| Total liabilities and stockholders equity | $151.3M | $152.3M | |
| Trade accounts receivable, allowance for credit losses | $375.0K | $423.0K | |
| Property and equipment, accumulated depreciation | $10.1M | $8.8M | |
| Preferred stock, par value (in USD per share) | $0.01 | $0.01 | |
| Preferred stock, shares authorized (in shares) | 5.0M shares | 5.0M shares | |
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in USD per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 20.0M shares | 20.0M shares | |
| Common stock, shares issued (in shares) | 12.6M shares | 12.5M shares | |
| Common stock, shares outstanding (in shares) | 12.5M shares | 12.4M shares | |
| Treasury stock, at cost (in shares) | 82.1K shares | 79.4K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $14.2M | $19.8M | |
| Restricted cash | $3.8M | $0 | |
| Trade accounts receivable, net of allowance for credit losses of $375 and $423, respectively | $25.9M | $29.5M | |
| Inventories | $31.6M | $26.8M | |
| Prepaid expenses and other current assets | $3.1M | $2.6M | |
| Total current assets | $78.6M | $78.8M | |
| Property and equipment, net of accumulated depreciation of $10,083 and $8,830, respectively | $4.8M | $4.5M | |
| Right-of-use assets, net | $9.1M | $10.8M | |
| Goodwill | $32.4M | $30.7M | $21.7M |
| Intangible assets, net | $24.9M | $26.4M | |
| Deferred tax assets | $775.0K | $67.0K | |
| Other assets | $789.0K | $1.1M | |
| Total assets | $151.3M | $152.3M | |
| Current portion of long-term debt | $6.1M | $7.5M | |
| Current portion of operating lease liabilities | $2.1M | $2.0M | |
| Accounts payable | $11.2M | $8.0M | |
| Customer deposits and deferred revenue | $6.4M | $5.0M | |
| Accrued expenses and other current liabilities | $10.0M | $9.5M | |
| Total current liabilities | $35.8M | $31.9M | |
| Operating lease liabilities, net of current portion | $7.4M | $9.0M | |
| Long-term debt, net of current portion | $1.4M | $7.5M | |
| Contingent consideration, net of current portion | $356.0K | $825.0K | |
| Deferred revenue, net of current portion | $1.1M | $1.4M | |
| Other liabilities | $1.7M | $1.7M | |
| Total liabilities | $47.7M | $52.5M | |
| Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding | $0 | $0 | |
| Common stock, $0.01 par value; 20,000,000 shares authorized; 12,570,865 and 12,457,658 shares issued, respectively; 12,488,788 and 12,378,276 shares outstanding, respectively | $125.0K | $124.0K | |
| Additional paid-in capital | $59.4M | $57.7M | |
| Retained earnings | $42.6M | $45.1M | |
| Accumulated other comprehensive earnings (loss) | $2.5M | -$2.1M | |
| Treasury stock, at cost; 82,077 and 79,382 shares, respectively | -$959.0K | -$942.0K | |
| Total stockholders equity | $103.6M | $99.8M | $96.3M |
| Total liabilities and stockholders equity | $151.3M | $152.3M | |
| Trade accounts receivable, allowance for credit losses | $375.0K | $423.0K | |
| Property and equipment, accumulated depreciation | $10.1M | $8.8M | |
| Preferred stock, par value (in USD per share) | $0.01 | $0.01 | |
| Preferred stock, shares authorized (in shares) | 5.0M shares | 5.0M shares | |
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in USD per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 20.0M shares | 20.0M shares | |
| Common stock, shares issued (in shares) | 12.6M shares | 12.5M shares | |
| Common stock, shares outstanding (in shares) | 12.5M shares | 12.4M shares | |
| Treasury stock, at cost (in shares) | 82.1K shares | 79.4K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net (loss) earnings | -$2.5M | $2.9M |
| Depreciation and amortization | $6.8M | $5.4M |
| Provision for excess and obsolete inventory | $818.0K | $703.0K |
| Amortization of deferred compensation related to stock-based awards | $1.6M | $1.9M |
| Deferred income tax benefit | -$1.0M | -$1.5M |
| Other non-cash reconciling items | -$344.0K | $295.0K |
| Trade accounts receivable | $4.5M | -$5.5M |
| Inventories | -$4.2M | $4.9M |
| Prepaid expenses and other current assets | $331.0K | $903.0K |
| Other assets | -$197.0K | -$30.0K |
| Operating lease liabilities | -$2.1M | -$1.6M |
| Accounts payable | $3.2M | -$2.3M |
| Customer deposits and deferred revenue | $975.0K | -$1.4M |
| Domestic and foreign income taxes payable | $119.0K | -$1.4M |
| Deferred revenue, net of current portion | -$377.0K | -$16.0K |
| Accrued expenses and other liabilities | -$297.0K | $649.0K |
| Net cash provided by operating activities | $7.3M | $3.8M |
| Acquisition of business, net of cash acquired | $0 | -$18.7M |
| Purchases of property and equipment | -$1.6M | -$1.3M |
| Net cash used in investing activities | -$1.6M | -$20.1M |
| Repayments of short-term borrowings, net of proceeds | -$4.3M | -$152.0K |
| Repayments of long-term debt | -$4.1M | -$7.7M |
| Repurchases of common stock | $0 | -$1.0M |
| Proceeds from stock options exercised | $22.0K | $145.0K |
| Proceeds from shares sold under Employee Stock Purchase Plan | $124.0K | $138.0K |
| Settlement of employee tax liabilities in connection with treasury stock transaction | -$17.0K | -$41.0K |
| Net cash used in financing activities | -$8.2M | -$8.6M |
| Effects of exchange rates on cash | $770.0K | -$559.0K |
| Net cash used in all activities | -$1.8M | -$25.4M |
| Interest | $456.0K | $881.0K |
| Total income taxes paid net of refunds received | $193.0K | $3.1M |
| Equity issued in conjunction with acquisition of business | $0 | $2.1M |
| Issuance of unvested shares of restricted stock awards | $1.0M | $1.6M |
| Forfeiture of shares of unvested restricted stock awards | -$557.0K | -$200.0K |
No quarter-by-quarter statement was filed.
Corporate structure
INTEST CORP sits at the top of its group. 12 entities, 6 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of INTEST CORP
- ASKELADDEN CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G/A on INTEST CORP, latest Aug 7, 2026 (2 filings since Apr 14, 2025)
- VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G/A on INTEST CORP, latest Jul 31, 2026 (2 filings since Apr 30, 2026)
- BlackRock Filed SCHEDULE 13G on INTEST CORP, latest Jul 28, 2026 (3 filings since Jan 26, 2024)
- Thomas A. Satterfield Jr. Filed SCHEDULE 13G/A on INTEST CORP, latest Apr 29, 2026 (5 filings since Feb 14, 2022)
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on INTEST CORP, latest Mar 27, 2026 (2 filings since Feb 13, 2024)
- ROYCE & ASSOCIATES LP Filed SCHEDULE 13G/A on INTEST CORP, latest Jan 28, 2025 (5 filings since Jan 23, 2024)
- RENAISSANCE TECHNOLOGIES LLC Filed SCHEDULE 13G/A on INTEST CORP, latest Nov 13, 2024 (4 filings since Feb 11, 2022)
- Pacific Ridge Capital Partners, LLC Filed SC 13G/A on INTEST CORP, latest Feb 12, 2024 (3 filings since Feb 14, 2022)
- Juniper Investment Company, LLC Filed SC 13D on INTEST CORP, latest Mar 29, 2023 (2 filings since Oct 3, 2022)
- 272 Capital LP Filed SC 13G/A on INTEST CORP, latest Feb 16, 2023
- DIMENSIONAL FUND ADVISORS LP Filed SC 13G/A on INTEST CORP, latest Feb 10, 2023 (2 filings since Feb 8, 2022)
- INTEST CORP Mount Laurel, New Jersey, United States
- Acculogic GmbH Subsidiary · Germany
- Alfamation S.p.A. Subsidiary · Italy
- Ambrell B.V. Subsidiary · Netherlands
- InTest EMS LLC (a) Subsidiary · Delaware, United States
- InTest Italy Subsidiary · Delaware, United States
- InTest SE Asia Sdn Bhd Subsidiary · Malaysia
- InTest Silicon Valley Corporation (a) Subsidiary · Delaware, United States
- InTest Thermal Solutions GmbH Subsidiary · Germany
- Suzhou Alfa Testing Equipment Co. Ltd. Subsidiary · China
- Temptronic Corporation (b) Subsidiary · Delaware, United States
- Videology Imaging Corporation Subsidiary · Delaware, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What INTEST CORP reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Machinery and equipment | $9.2M11 Dec 31, 2024 | $7.1M11 Dec 31, 2023 | +28.7% |
| Leasehold improvements | $4.1M11 Dec 31, 2024 | $3.6M11 Dec 31, 2023 | +14.6% |
| Property and equipment, before depreciation | $14.9M6 Dec 31, 2025 | $13.3M6 Dec 31, 2024 | +11.8% |
| Accumulated depreciation | $10.1M6 Dec 31, 2025 | $8.8M6 Dec 31, 2024 | +14.2% |
| Property and equipment, net | $4.8M6 Dec 31, 2025 | $4.5M6 Dec 31, 2024 | +7.2% |
| Operating-lease assets (leased space) | $9.1M6 Dec 31, 2025 | $10.8M6 Dec 31, 2024 | −15.5% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $14.2M6 Dec 31, 2025 | $19.8M6 Dec 31, 2024 | −28.3% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $32.4M6 Dec 31, 2025 | $30.7M6 Dec 31, 2024 | +5.3% |
| Intangible assets, net (excluding goodwill) | $24.9M6 Dec 31, 2025 | $26.4M6 Dec 31, 2024 | −5.7% |
| Indefinite-lived intangibles (excluding goodwill) | $10.5M6 Dec 31, 2025 | $10.2M6 Dec 31, 2024 | +3.2% |
| Finite-lived intangibles, gross | $32.5M6 Dec 31, 2025 | $31.2M6 Dec 31, 2024 | +4.1% |
| Accumulated amortization | $18.1M6 Dec 31, 2025 | $15.0M6 Dec 31, 2024 | +20.8% |
| Finite-lived intangibles, net | $14.4M6 Dec 31, 2025 | $16.2M6 Dec 31, 2024 | −11.3% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $31.6M6 Dec 31, 2025 | $26.8M6 Dec 31, 2024 | +17.7% |
| Raw materials | $16.4M6 Dec 31, 2025 | $16.1M6 Dec 31, 2024 | +1.9% |
| Work in process | $9.4M6 Dec 31, 2025 | $5.9M6 Dec 31, 2024 | +58.2% |
| Finished goods | $5.5M6 Dec 31, 2025 | $4.5M6 Dec 31, 2024 | +22.5% |
Properties, in its own words
As of December 31, 2025, we leased 13 facilities worldwide. The following chart provides information regarding each of our principal leased facilities as of December 31, 2025:
Location · LeaseExpiration · Approx.SquareFootage · Principal Uses
The rest of Item 2
Rochester, NY · April 2028 · 79,150 · Process Technologies segment operations (principal facility for Ambrell®)
Mansfield, MA · February 2032 · 58,800 · Environmental Technologies segment operations (principal facility for ITS), Process Technologies segment operations (principal facility for Videology®)
Milan, Italy · February 2030 · 51,871 · Electronic Test segment operations (principal facility for Alfamation™)
Mt. Laurel, NJ · April 2031 · 33,650 · Corporate headquarters and Electronic Test segment operations
Penang, Malaysia · June 2027 · 25,000 · Applications engineering, product development and localized manufacturing for nearly all InTest brands
Markham, Ontario, Canada · February 2028 · 16,437 · Electronic Test segment operations (principal facility for Acculogic Inc.)
All of our facilities have space to accommodate our needs for the foreseeable future.
Item 2 of the 10-K filed Mar 12, 2026.5
Leadership
Who has led INTEST CORP, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
2010201520202025
- Chief executive officerRichard B. Rogoff Apr 2, 2026 to now15
- Chief executive officerRichard N. Grant Jr. Aug 24, 2020 to Apr 2, 202616
- Chief executive officerJames Pelrin Mar 14, 2018 to Mar 11, 202017
- Chief executive officerRobert E. Matthiessen Nov 28, 2006 to Oct 30, 201718
- ChairRobert E. Matthiessen May 16, 2017 to Oct 30, 201719
- ChairAlyn R. Holt Dec 14, 2007 to Mar 15, 201720
- PresidentRichard B. Rogoff Jun 13, 2025 to now21
- PresidentMichael Tanniru May 9, 2023 to Jun 13, 202522
- PresidentRichard N. Grant Jr. Aug 24, 2020 to May 9, 202316
- PresidentJames Pelrin Mar 14, 2018 to Mar 11, 202017
- PresidentRobert E. Matthiessen Nov 28, 2006 to Oct 30, 201718
- Chief financial officerDuncan Gilmour Jun 14, 2021 to now23
- Chief financial officerHugh T. Regan Jr. Nov 28, 2006 to Mar 11, 202124
Board members and other officers (21)
- Division Pres-Process TechMichael F. Goodrich Jan 18, 2024 to now25
- Division Pres-Electronic TestJoseph Richard McManus Jr. Mar 25, 2022 to now26
- Division Pres-Process TechScott Eric Nolen Mar 25, 2022 to Feb 9, 202427
- VP&GM-Environmental TechGregory Martel Mar 28, 2022 to May 2, 202228
- GM-Temp Mgmt Product SegmentJames Pelrin Apr 12, 2006 to Mar 17, 201729
- GM-Tester Interface Prod SgmtDale E. Christman Aug 7, 2006 to Mar 10, 200930
- Sr VP&GM-Manipulator&Dkg SegmDaniel J. Graham Nov 28, 2006 to Jan 8, 201631
- Board memberRichard B. Rogoff Apr 2, 2026 to now15
- Board memberKarl E. Johnsen Jun 22, 2026 to now32
- Board memberGerald J. Maginnis Jun 25, 2020 to now33
- Board memberRichard N. Grant Jr. Aug 24, 2020 to now16
- Board memberJeffrey A. Beck Jun 24, 2019 to now34
- Board memberJames Pelrin Mar 14, 2018 to Mar 11, 202017
- Board memberJoseph W. Dews Iv. Apr 14, 2014 to now35
- Board memberSteven J. Abrams Jan 10, 2013 to now36
- Board memberWilliam Kraut Jan 10, 2013 to Mar 10, 202037
- Board memberJames J. Greed Jr. Mar 8, 2007 to Mar 15, 201038
- Board memberJames W. Schwartz Mar 8, 2007 to Mar 15, 201039
- Board memberRichard O. Endres May 18, 2006 to Aug 17, 200640
- Board memberStuart F. Daniels Aug 7, 2006 to Mar 8, 201141
- Board memberRobert E. Matthiessen Nov 28, 2006 to Jun 24, 201918
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Acculogic GmbH Germany4
- Acculogic Inc. Ontario4
- Acculogic Ltd Delaware4
- Alfamation S.p.A. Italy4
- Ambrell B.V. Netherlands4
- Ambrell Corporation Delaware4
- InTest EMS LLC (a) Delaware4
- InTest Italy Delaware4
- InTest PTE, Ltd. Singapore4
- InTest SE Asia Sdn Bhd Malaysia4
- InTest Silicon Valley Corporation (a) Delaware4
- InTest Thermal Solutions GmbH Germany4
- Suzhou Alfa Testing Equipment Co. Ltd. China4
- Temptronic Corporation (b) Delaware4
- Videology Imaging Corporation Delaware4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Oct 5, 20268-K Results of operations42
- Aug 17, 20268-K Entered a material agreement; New debt or obligation43
- Aug 10, 20268-K Results of operations44
- Jul 31, 20268-K Results of operations; Regulation FD disclosure45
- Jun 18, 20268-K Shareholder vote46
- May 5, 20268-K Entered a material agreement; Results of operations; New debt or obligation47
- Apr 10, 20268-K Executive or director change48
- Apr 2, 2026New chief executive Richard B. Rogoff becomes CEO15
- Apr 2, 20268-K Executive or director change; Other events49
- Mar 6, 20268-K Executive or director change50
- Feb 27, 20268-K Results of operations51
- Nov 5, 20258-K Results of operations52
- Aug 6, 20258-K Results of operations53
- Aug 24, 2020New chief executive Richard N. Grant Jr. becomes CEO16
- Mar 14, 2018New chief executive James Pelrin becomes CEO17
- Nov 28, 2006New chief executive Robert E. Matthiessen becomes CEO18
- Mar 21, 1997Founded INTEST CORP is founded2
Calendar
Coming up
- Nov 6, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported ($0.02) a share, on Nov 5, 2025.54
When it reported results
- Oct 5, 2026Reported quarterly or annual results42
- Aug 10, 2026Reported quarterly or annual results44
- Jul 31, 2026Reported quarterly or annual results45
- May 5, 2026Reported quarterly or annual results47
- Feb 27, 2026Reported quarterly or annual results51
- Nov 5, 2025Reported quarterly or annual results52
- Aug 6, 2025Reported quarterly or annual results53
- May 2, 2025Reported quarterly or annual results55
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
249 filings to the SEC since October 2021: 5 annual reports, 16 quarterly reports, 60 major events, 97 insider forms, 31 large holders, 40 other. The latest 20:
- Oct 13, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 5, 20268-K EDGAR
- Oct 5, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Sep 2, 2026S-8 EDGAR
- Aug 17, 20268-K EDGAR
- Aug 10, 202610-Q EDGAR
- Aug 10, 20268-K EDGAR
- Aug 7, 2026SCHEDULE 13G/A EDGAR
- Jul 31, 2026SCHEDULE 13G/A EDGAR
- Jul 31, 20268-K EDGAR
- Jul 28, 2026SCHEDULE 13G EDGAR
- Jul 10, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Jul 1, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Jun 22, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Jun 22, 20263 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Jun 18, 20268-K EDGAR
- Jun 18, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- May 28, 2026SD EDGAR
- May 11, 202610-Q EDGAR
- May 5, 20268-K EDGAR
The 249 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
19 open-market trades by officers, directors and large owners since October 2021: 6 buys and 13 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Grant Richard N. Jr.President & CEO | Sale | 1,636 | $14.28 | $23.4K | Form 4 |
| Mar 11, 2026 | Grant Richard N. Jr.President & CEO | Sale | 1,397 | $14.16 | $19.8K | Form 4 |
| Mar 9, 2026 | Grant Richard N. Jr.President & CEO | Sale | 1,097 | $13.33 | $14.6K | Form 4 |
| Nov 19, 2025 | Maginnis Gerald J.Director | Buy | 6,000 | $7.44 | $44.6K | Form 4 |
| May 12, 2025 | DEWS JOSEPH W IVDirector | Buy | 4,000 | $5.86 | $23.4K | Form 4 |
| May 6, 2025 | Maginnis Gerald J.Director | Buy | 7,557 | $5.78 | $43.7K | Form 4 |
| Mar 11, 2025 | Grant Richard N. Jr.President & CEO | Sale | 1,184 | $7.57 | $9.0K | Form 4 |
| Mar 10, 2025 | Grant Richard N. Jr.President & CEO | Sale | 2,688 | $7.48 | $20.1K | Form 4 |
| Aug 27, 2024 | Grant Richard N. Jr.President & CEO | Sale | 6,788 | $6.97 | $47.3K | Form 4 |
| Aug 14, 2024 | DEWS JOSEPH W IVDirector | Buy | 10,900 | $6.80 | $74.1K | Form 4 |
| Aug 13, 2024 | Maginnis Gerald J.Director | Buy | 1,750 | $6.42 | $11.2K | Form 4 |
| Apr 11, 2024 | Grant Richard N. Jr.President & CEO | Sale | 21,500 | $12.03 | $258.6K | Form 4 |
| Apr 10, 2024 | Grant Richard N. Jr.President & CEO | Sale | 22,000 | $12.03 | $264.7K | Form 4 |
| Apr 9, 2024 | Grant Richard N. Jr.President & CEO | Sale | 20,000 | $12.80 | $256.0K | Form 4 |
| Jun 12, 2023 | DEWS JOSEPH W IVDirector | Sale | 11,250 | $26.23 | $295.1K | Form 4 |
| May 15, 2023 | Nolen Scott EricDivision Pres-Process Tech | Sale | 7,597 | $21.14 | $160.6K | Form 4 |
| Aug 24, 2022 | Grant Richard N. Jr.President & CEO | Sale | 4,153 | $9.26 | $38.5K | Form 4 |
| May 9, 2022 | DEWS JOSEPH W IVDirector | Buy | 9,235 | $6.79 | $62.7K | Form 4 |
| Mar 10, 2022 | Grant Richard N. Jr.President & CEO | Sale | 1,167 | $9.50 | $11.1K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- ASKELADDEN CAPITAL MANAGEMENT LLCSCHEDULE 13G/A, 2 filings Apr 14, 2025 to Aug 7, 202656
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G/A, 2 filings Apr 30, 2026 to Jul 31, 202657
- BlackRockSCHEDULE 13G, 3 filings Jan 26, 2024 to Jul 28, 202658
- Thomas A. Satterfield Jr.SCHEDULE 13G/A, 5 filings Feb 14, 2022 to Apr 29, 202659
- VANGUARD GROUP INCSCHEDULE 13G/A, 2 filings Feb 13, 2024 to Mar 27, 202660
- ROYCE & ASSOCIATES LPSCHEDULE 13G/A, 5 filings Jan 23, 2024 to Jan 28, 202561
- RENAISSANCE TECHNOLOGIES LLCSCHEDULE 13G/A, 4 filings Feb 11, 2022 to Nov 13, 202462
- Pacific Ridge Capital Partners, LLCSC 13G/A, 3 filings Feb 14, 2022 to Feb 12, 202463
- Juniper Investment Company, LLCSC 13D, 2 filings Oct 3, 2022 to Mar 29, 202364
- 272 Capital LPSC 13G/A, 1 filing Feb 16, 202365
- DIMENSIONAL FUND ADVISORS LPSC 13G/A, 2 filings Feb 8, 2022 to Feb 10, 202366
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Richard N. GrantJr. | $428.9K | $1.1M67 | |
| 2025 | Duncan Gilmour | 53 | $282.5K | $610.7K67 |
| 2025 | Joseph McManus | 52 | $284.5K | $444.1K67 |
| 2024 | President and Chief Executive Officer | $425.0K | $1.1M67 | |
| 2024 | Chief Financial OfficerTreasurer and Secretary | $280.5K | $581.2K67 | |
| 2024 | Division PresidentElectronic Test | $281.5K | $517.2K67 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 90. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How INTEST CORP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARINTEST CORP1
- CIK0001036262
- Employer ID (EIN)22-23706595
- Filer statusAccelerated filer not an emerging growth company; a smaller reporting company; not a shell company5
- Incorporated inDelaware5
- Fiscal year endsDecember 311
- Industry code (SIC)3825 Instruments For Meas & Testing of Electricity & Elec Signals1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address804 East Gate Dr., Suite 200, Mt. Laurel, NJ 080541
- Phone856-505-88001
- Shares outstanding12,564,657 as of Apr 30, 202614
- Public float$85.4M as of Jun 30, 20255
- AuditorRSM US LLP, Blue Bell, Pennsylvania PCAOB ID 49; it also attests to the company’s internal control over financial reporting5
- On EDGAR sinceMay 2, 19971
- Filings1,088 in all: 4 (317), 8-K (266), SC 13G/A (102), 10-Q (88), 5 (36), SC 13G (30), 10-K (29), DEF 14A (29)1
All 43 form types
3 (27), SC 13D/A (16), 8-K/A (14), S-8 (13), SD (13), ARS (12), SCHEDULE 13G/A (9), 10-K/A (8), 144 (8), DEFA14A (7), SC 13D (7), S-3 (6), EFFECT (5), CORRESP (4), S-3/A (4), S-8 POS (4), UPLOAD (4), 10-Q/A (3), 4/A (3), DEFR14A (3), S-1/A (3), SCHEDULE 13G (3), CERTNYS (2), NT 10-K (2), 25 (1), 3/A (1), 424B1 (1), 424B5 (1), 8-A12B (1), 8-A12G (1), 8-A12G/A (1), NT 10-Q (1), RW (1), S-1 (1), S-4 (1)
- Latest filingsAnnual report (10-K) Mar 12, 2026
Quarterly report (10-Q) Aug 10, 2026
Proxy statement (DEF 14A) Apr 28, 2026
Latest 8-K (8-K) Oct 5, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.01 per share | INTT | NYSE American |
From the cover page of the 10-K filed Mar 12, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks INTEST CORP names in Item 1A of its 10-K filed Mar 12, 2026: 30 risks under these headings, as written.5
- RISKS RELATED TO OUR ACQUISITION AND GROWTH STRATEGY
- We seek to grow our business through the acquisition of additional businesses. If we are unable to do so, our future rate of growth may be reduced or limited. We may incur significant expenses related to due diligence or other transaction-related expenses for a proposed acquisition that may not be completed.
- Our acquisition strategy involves financial and management risks which may adversely affect our results in the future.
- We may attempt to acquire a business that would require us to issue equity or incur significant debt from third parties. If we are unable to secure sufficient financing at terms that are acceptable to us, we may not be able to close the proposed acquisition. Additionally, should we incur significant debt, we may not be able to achieve compliance with all covenants related to the debt depending on our financial results in future periods.
- We may acquire businesses in the future and utilize an earnout structure as we have done in prior transactions we have closed. In connection with the earnout, we may be required to accrue significant increases or decreases to the contingent consideration liability we would establish. These adjustments to the contingent consideration liability could cause our results of operations to have increased variability, which may negatively impact our stock’s trading price.
- We may not be able to effectively manage our growth and operations, which could materially and adversely affect our business.
- We may fail to effectively integrate acquired businesses into our operations or otherwise fail to realize the anticipated benefits of the acquisitions.
- RISKS RELATED TO OUR MARKETS
- Our sales are affected by the cyclicality of the Semi market, which causes our operating results to fluctuate significantly.
- We seek to further diversify the markets for our products in order to increase the proportion of our sales attributable to markets which are less subject to cyclicality than the Semi market. If we are unable to do so, our future performance will remain substantially exposed to the fluctuations of the cyclicality of the Semi market.
- RISKS RELATED TO OUR BUSINESS OPERATIONS
- If our suppliers do not meet product or delivery requirements, or inflationary pressures continue to increase and we cannot increase our prices to our customers, we could have reduced revenues and earnings.
The other 21 risks
- A breach of our operational or security systems could negatively affect our business, our reputation and results of operations.
- Risks related to artificial intelligence technologies, including generative AI, could adversely affect our products, operations, intellectual property, and reputation.
- We are subject to significant environmental, health and safety laws and regulations and related compliance expenditures and liabilities.
- If material weaknesses in our internal control over financial reporting are identified in the future, we may not be able to report our financial results accurately, prevent fraud or file our periodic reports in a timely manner, which may adversely affect investor confidence in our Company and, as a result, the value of our common stock.
- Our business may suffer if we are unable to attract and retain key employees or hire personnel at the costs we currently project.
- We have experienced and may continue to experience significant variability in our effective tax rates and may have exposure to additional tax liabilities and costs.
- The terms and covenants relating to our credit facility could adversely impact our ability to pursue our strategy and our financial performance and liquidity, and thus we may need additional financial resources to maintain our liquidity.
- We hold our cash and cash equivalents that we use to meet our working capital needs in deposit accounts that could be adversely affected if the financial institutions holding such funds fail.
- We face risks associated with doing business in China.
- We face political and other risks conducting business in Taiwan particularly due to their tense relationships with China.
- U.S. tariff policies and potential global retaliatory countermeasures could increase our cost, disrupt our supply chain or affect customer purchasing activities, any of which could negatively impact our results of operations.
- RISKS RELATED TO OUR CUSTOMER BASE
- Changes in the buying patterns of our customers have affected, and may continue to affect, demand for our products and our gross and net operating margins. Such changes in patterns are difficult to predict and may not be immediately apparent.
- We generate a large portion of our sales from a small number of customers. If we were to lose one or more of our large customers, our operating results could be materially and adversely affected.
- RISKS RELATED TO COMPETITION
- Our markets are subject to rapid technological change, and our business prospects would be negatively affected if we are unable to quickly and effectively respond to innovation in the Semi market or other markets that we serve.
- RISKS RELATED TO FOREIGN OPERATIONS
- The continuing conflict in the Ukraine could disrupt our supply chain or cause other adverse effects on our revenue and earnings.
- We have a sole source supplier of components in Israel and the continuing conflicts in the Middle East could disrupt our supply chain or cause other adverse effects on our revenue and earnings.
- A substantial portion of our customers are located outside the U.S., which exposes us to foreign political and economic risks.
- A significant portion of our cash position is maintained overseas and we may not be able to repatriate cash from overseas when necessary, which could have an adverse effect on our financial condition.
- RISKS RELATED TO INTELLECTUAL PROPERTY
- Claims of intellectual property infringement by or against us could seriously harm our businesses.
- If we are unable to protect our intellectual property, we may lose a valuable asset or may incur costly litigation to protect our rights.
- RISKS RELATED TO OUR OPERATING RESULTS AND STOCK PRICE
- Our operating results often change significantly from quarter to quarter and may cause fluctuations in our stock price.
Legal proceedings
From time to time we may be a party to legal proceedings occurring in the ordinary course of business. We are not currently involved in any material legal proceedings.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARINTEST CORP filings on SEC EDGAR
- 2
- 3SEC EDGARINTEST CORP filings on SEC EDGAR
- 4
- 5
- 6SEC EDGARINTEST CORP 10-K for fiscal 2025
- 7SEC EDGARINTEST CORP 10-K for fiscal 2019
- 8SEC EDGARINTEST CORP 10-K for fiscal 2020
- 9SEC EDGARINTEST CORP 10-K for fiscal 2021
- 10SEC EDGARINTEST CORP 10-K for fiscal 2022
- 11SEC EDGARINTEST CORP 10-K for fiscal 2023
- 12SEC EDGARINTEST CORP 10-Q for fiscal 2025
- 13SEC EDGARINTEST CORP 10-Q for fiscal 2025
- 14SEC EDGARINTEST CORP 10-Q for fiscal 2026
- 15
- 16
- 17
- 18
- 19SEC EDGARRobert E. Matthiessen, Chair
- 20SEC EDGARAlyn R. Holt, Chair
- 21SEC EDGARRichard B. Rogoff, President
- 22SEC EDGARMichael Tanniru, President
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32SEC EDGARKarl E. Johnsen, Board member
- 33SEC EDGARGerald J. Maginnis, Board member
- 34SEC EDGARJeffrey A. Beck, Board member
- 35SEC EDGARJoseph W. Dews Iv., Board member
- 36SEC EDGARSteven J. Abrams, Board member
- 37SEC EDGARWilliam Kraut, Board member
- 38SEC EDGARJames J. Greed Jr., Board member
- 39SEC EDGARJames W. Schwartz, Board member
- 40SEC EDGARRichard O. Endres, Board member
- 41SEC EDGARStuart F. Daniels, Board member
- 42SEC EDGARResults of operations
- 43
- 44SEC EDGARResults of operations
- 45
- 46SEC EDGARShareholder vote
- 47
- 48SEC EDGARExecutive or director change
- 49
- 50SEC EDGARExecutive or director change
- 51SEC EDGARResults of operations
- 52SEC EDGARResults of operations
- 53SEC EDGARResults of operations
- 54NasdaqNasdaq calendar
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67